AGEs increase cardiovascular risk in T2DM
As reported in Diabetes, elevated advanced glycation end products increase the risk for incident cardiovascular events (HR=1.31) in type 2 diabetics (n=218).
Statin use associated with decreased mortality in HFPEF
Based on a meta-analysis reported in the American Journal of Cardiology, statin use by patients (n=17985) with heart failure with preserved ejection fraction (HFPEF) is associated with a 40% reduction in mortality.
Fructosamine and glycated albumin predict incident diabetes
As reported in The Lancet, fructosamine and glycated albumin > 95th percentile predicted incident diabetes (HR=4.96 and 6.17, respectively) and retinopathy and chronic kidney disease among 958 and 11348 patients with and without diabetes, respectively, followed for 20 years.